Sionna Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $7.25-$45 |
Market Cap | $1.6B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.88 |
News
See moreYahoo Finance • 8 days ago
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch
Yahoo Finance • 14 days ago
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
Yahoo Finance • 27 days ago
Sionna Therapeutics GAAP EPS of -$0.46
Yahoo Finance • 3 months ago
Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls
About
CEO | Mr. Michael Cloonan M.B.A. |
Address | 21 Hickory Drive, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
